Effect of Cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty

American Journal of Cardiology

Volumn 79, Issue 8, 1997, Pages 1097-1099

  Take, Shunsuke ^a   Matsutani, Masahide ^b   Ueda, Hiroyasu ^b   Hamaguchi, Hidehito ^b   Konishi, Hiroki ^b   Baba, Yuji ^b   Kawaratani, Hitoshi ^b   Sugiura, Tetsuro ^b   Iwasaka, Toshiji ^b   Inada, Mitsuo ^b  

^a Dept of Respiratory Medicine Saiseikai Noe Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOSORBIDE DINITRATE; TICLOPIDINE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; FEMALE; HUMAN; INTRACORONARY INFUSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; TETRAZOLES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 8244220339     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00052-0     Document Type: Article

References (14)

1. Thornton MA, Gruentzig AR, Hollman J. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984;69:721-727.
2. Okamoto S. PDGF antagonist on post-PTCA restenosis. Am Heart J 1992;123:1439-1444.
3. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.
4. Scwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988;318:1714-1719.
5. Brozovich FV. Effect of ACE inhibition on restenosis. Cathet Cardiovasc Diagn 1991;23:263-267.
6. MERCATOR Study Group. Cilazapril and restenosis prevention. Circulation 1992;86:100-110.
7. MERCATOR study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992;86:100-110.
8. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS, King SB III, Gruentzig AR. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-1276.
9. Corcos T, David PR, Val PG, Renkin J, Dangoisse V, Rapold HG, Bourassa MG. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-931.
10. Reis GJ, Sipperly ME, Boucher TM, Silverman DI, McCabe CH, Baim DS, Sacks FM, Grossmaan W, Pasternak RC. Randomized trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989;2:177-181.
11. Dehmer GJ, Pompa JJ, van den Berg EK. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988;319:733-740.
12. Okuda Y, Kimura Y, Yamashita K. Cilostazol. Cardiovasc Drug Rev 1993;11:451-465.
13. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JCH, den Boer A, Hugenholtz PG. Assessment of short-, medium-, and long-term variations in arterial dimensions from comuter-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-288.
14. Zwet PMJ, van der Pinto IMF, Serruys PW, Reiber JHC. A new approach for the automated definition of path lines in digitized coronary angiograms. Int J Cardiac Imaging 1990;5:75-83.